When several good embryos have been transferred and none implanted, the next clinic you contact abroad may answer with a long list of tests and add-on treatments. Some of them are worth doing. Many are not, and a few will cost more than another transfer.
The most useful yardstick is the European Society of Human Reproduction and Embryology (ESHRE) good practice paper on recurrent implantation failure (RIF), published in 2023. This guide walks through what it says, what you can do at home before booking another trip, and how to tell a careful workup from a padded one.
What ESHRE means by recurrent implantation failure
ESHRE treats RIF as something that only exists in the context of assisted reproduction. It describes the situation where embryos considered viable have been transferred, and they have failed to produce a positive pregnancy test often enough, for that specific patient, to justify looking for a cause or trying something different.1
The key word is individual. ESHRE did not set a fixed number of failed transfers. Instead, it recommends a threshold based on your cumulative predicted chance of implantation: once that predicted chance across your transfers has passed 60% and you still have not had an implantation, you should be counseled about further investigation or treatment.12
In practice, that predicted chance depends on things like your age when the eggs were collected, embryo stage and quality, whether the embryos had chromosome testing, and how many were transferred. Two people with three failed transfers each can be in very different places. One may have crossed the threshold; the other may simply have had expected bad luck.
If a clinic labels you "RIF" after a set count of failures without estimating your predicted odds, it is using a simpler rule than the one ESHRE adopted. Ask how they reached the label before you agree to anything built on it.
How ESHRE grades the tests and treatments
The paper contains 19 recommendations on investigations and 13 on interventions. Each one sits in one of three categories: recommended, can be considered, or not recommended for routine use.1
It helps to know how the paper was made. An ESHRE working group of eight members, with an independent chair and a statistics expert, drew on a literature search, an earlier survey of clinical practice and expert opinion. ESHRE members then commented on a draft online.1 ESHRE has published the report of that review round.3
That makes it a good practice paper, not a guideline built on large trials. For many RIF questions, the trials simply do not exist. The authors' central caution is that investigations and treatments should be limited to those "supported by a clear rationale and data indicating their likely benefit."4
The RIF workup: what ESHRE recommends, allows and advises against
The table below summarizes the investigations as they appear in the paper's text. Use it as a checklist against any test list a clinic sends you.
| Test or step | ESHRE category | Notes |
|---|---|---|
| Review of lifestyle factors (smoking, weight, alcohol, caffeine) | Recommended | Behavior can change, so it should be reviewed and optimized2 |
| Re-assessment of endometrial thickness | Recommended | If the lining stays thin, the paper advises reviewing the estrogen regimen4 |
| Karyotyping of both partners | Can be considered | Low yield, but confirms there is no chromosomal rearrangement; genetic counseling and PGT are recommended if one is found2 |
| 3D transvaginal ultrasound | Can be considered | If not already done during the original fertility workup2 |
| Hysteroscopy | Can be considered | Especially when ultrasound suggests a uterine anomaly2 |
| HSG or other tubal imaging | Can be considered | Only if a hydrosalpinx is still in doubt after ultrasound2 |
| Assessment for chronic endometritis | Can be considered | Antibiotic treatment can be considered if it is diagnosed2 |
| Antiphospholipid antibodies | Can be considered | Even without risk factors4 |
| Thyroid function | Can be considered | Listed as an option, not a routine requirement4 |
| Late follicular and mid-luteal progesterone | Can be considered | Relevant to how the transfer cycle is prepared4 |
| Tests of specific aspects of endometrial function | Can be considered | Distinct from commercial receptivity tests (next rows)2 |
| Commercial endometrial receptivity tests | Not recommended for routine use | Insufficient data for routine use of any commercial test2 |
| Vitamin D measurement | Not recommended for routine use | Insufficient data to measure or treat routinely2 |
| Peripheral or uterine natural killer (NK) cell testing | Not recommended | Neither blood nor uterine NK testing is recommended4 |
| Uterine T lymphocyte assessment | Not recommended | 4 |
| Uterine and vaginal microbiome profiling | Not recommended | 4 |
| MRI or diagnostic laparoscopy | Situational | Only if new suspicion of a problem arises2 |
On treatments for a thin lining, the paper describes the evidence for platelet-rich plasma (PRP) and G-CSF as limited or conflicting, with more studies needed. Lipid infusions and steroids, sometimes offered for suspected immune causes, still need randomized trials.4
The intervention section rates 13 treatments on the same three-level scale. Before paying for any intervention, ask the clinic which ESHRE category it falls in. If they are recommending something outside routine use, ask them to explain in writing why your case is the exception.
What to do at home before another trip
Most of the "recommended" and "can be considered" items are ordinary tests: bloodwork, ultrasound, and in some cases hysteroscopy. Your local fertility specialist or gynecologist can usually arrange them. Doing them at home means the clinic abroad receives results rather than a reason to schedule a diagnostic-only visit.
- Collect every transfer record. For each attempt: date, embryo stage and grade, whether it was chromosome-tested, how many were transferred, endometrial thickness, medications and protocol, and any notes on a difficult transfer. Our guide to sending fertility records to an overseas clinic covers formats and translation.
- Ask for an estimate of your cumulative predicted chance. A reproductive endocrinologist can tell you whether your history plausibly crosses the 60% threshold ESHRE uses, or whether another transfer of similar embryos is still reasonable.
- Cover the recommended steps first. A lifestyle review and a fresh look at endometrial thickness and the estrogen protocol cost little and are in ESHRE's top category.
- Add targeted "can be considered" tests only with a reason. For example, hysteroscopy if an ultrasound suggests a polyp or anomaly, or tubal imaging if a hydrosalpinx is suspected.
- Send results ahead and ask for a written plan. A second opinion from another clinic is worth having at this stage; see our piece on getting several international perspectives.
Severe pelvic pain, heavy bleeding, fever or fainting after any transfer or procedure needs prompt in-person care where you are. Do not wait for an email reply from a clinic abroad.
How to judge a clinic that offers a long test list
A long list is not automatically a bad sign. Some clinics send a menu and let you choose. What matters is whether the list is tied to your history and to the evidence, and whether each item is priced separately.
A workup that tracks ESHRE
- Starts by estimating your predicted chance and whether RIF applies
- Prioritizes lifestyle, endometrial thickness and the transfer protocol
- Adds imaging or karyotyping for a stated reason
- Prices each test and treatment as its own line
- Explains in writing any step outside routine use
A workup that should prompt questions
- Applies the RIF label from a failure count alone
- Bundles NK cell, T cell or microbiome panels
- Sells a receptivity test as standard for everyone
- Proposes immune treatments based on those panels
- Quotes one "RIF package" price with no breakdown
The UK regulator, the HFEA, keeps a public page rating the evidence for common treatment add-ons, which is a useful second check when a clinic outside the UK proposes extras.5 Bundled extras are one of the main ways quotes grow; our breakdown of hidden fees in IVF abroad shows where they tend to appear. If chromosome testing of embryos is part of the proposal, read what to verify about PGT-A abroad first.
When to change strategy instead of repeating the same cycle
A workup sometimes finds something specific. More often it does not, and the honest conclusion is that the limiting factor is likely the embryos, the odds, or both. Either way, the result should change the plan.
| Finding | What ESHRE says | Practical next step |
|---|---|---|
| Chromosomal rearrangement in a partner | Genetic counseling and PGT recommended2 | Choose a clinic with a genetics service and check PGT is legal in that country |
| Polyp, septum or other uterine finding | Hysteroscopy can be considered2 | Treat first, often at home, then plan the transfer |
| Suspected hydrosalpinx | Tubal imaging can be considered if in doubt2 | Get a surgical opinion before another transfer |
| Chronic endometritis diagnosed | Antibiotics can be considered2 | Complete treatment before traveling |
| Lining stays thin | Re-assess thickness; review estrogen regimen4 | Ask about protocol changes; be cautious about PRP or G-CSF |
| Nothing found; predicted chance passed 60% | Counsel about options1 | Discuss whether embryo quality is the limit and whether donor options fit |
If egg age or embryo quality is the likely limit, donor eggs are the change that most often comes up. Our donor egg IVF abroad guide covers how programs work, and Spain vs Czech Republic for donor eggs compares two common destinations. Donor embryos are another route; see embryo and gamete donation compared internationally.
Sometimes the right change is the clinic itself. If your first destination did not explain its reasoning or share full records, our guide to choosing a second destination after a failed attempt sets out what to look for.
Questions to ask before your next cycle abroad
- Based on my records, what do you estimate my cumulative predicted chance of implantation has been so far?
- Do you consider this recurrent implantation failure under ESHRE's 2023 definition, and why?
- Which of the tests you propose are in ESHRE's "recommended" or "can be considered" categories?
- For anything not recommended for routine use, what is the specific reason in my case?
- Can I do these tests at home and send the results instead?
- What will you change about the embryo, the lining or the protocol for the next transfer?
- What is the itemized price of each test and treatment, and what happens if results are normal?
- If this transfer fails, what would you recommend next, and at what point would you raise donor options?
When you have a written plan and itemized prices from more than one clinic, you can request a quote to compare destinations side by side. Our list of questions to ask any IVF clinic covers the broader checks on lab, staff and success reporting.
Repeated failed transfers take a real toll. Whatever the workup shows, it is reasonable to pause, get support, and make the next decision with your own doctor rather than on a clinic's timeline.